Corcept Therapeutics (CORT): Canaccord sees 111% price potential - Phase III data from the ROSELLA study could impress

Corcept Therapeutics Inc. (CORT) is focused on the development of drugs that modulate the effects of cortisol. Cortisol is a steroid hormone produced by the adrenal cortex. It plays a central role in various bodily functions. For example, cortisol is released during stress and helps the body cope with acute stressors. Additionally, it regulates blood sugar levels by promoting the conversion of proteins and fats into glucose. Cortisol also has anti-inflammatory effects and influences the immune system, helping to regulate blood pressure and the...